首页> 外文期刊>Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases >Elevated serum alanine aminotransferase (ALT) levels in patients with serologically verified Mycoplasma pneumoniae pneumonia.
【24h】

Elevated serum alanine aminotransferase (ALT) levels in patients with serologically verified Mycoplasma pneumoniae pneumonia.

机译:经血清学检查证实的肺炎支原体肺炎患者的血清丙氨酸氨基转移酶(ALT)水平升高。

获取原文
获取原文并翻译 | 示例
       

摘要

The possibility of liver involvement in Mycoplasma pneumoniae pneumonia is still controversial. This study investigated 33 adult patients with serologically confirmed M. pneumoniae community-acquired pneumonia (CAP) (median age 31 years) and 38 patients with bacteraemic Streptococcus pneumoniae CAP (median age 54 years), all without pre-existing liver disease. Serum alanine aminotransferase (ALT) levels were elevated in 12 (36.4%) patients with M. pneumoniae CAP (median 53.5 U/L), and in four (10.5%) patients with S. pneumoniae CAP (median 61 U/L) (p 0.025). In most patients with M. pneumoniae CAP, the elevated ALT levels decreased during macrolide therapy, although this decrease was not significant.
机译:肝参与肺炎支原体肺炎的可能性仍存在争议。这项研究调查了33例经血清学证实的肺炎支原体社区获得性肺炎(CAP)成人患者(中位年龄31岁)和38例细菌性肺炎链球菌CAP患者(中位年龄54岁),均未曾患有肝病。 12例(36.4%)肺炎支原体CAP(中位数53.5 U / L)和4例(10.5%)肺炎链球菌CAP(中位数61 U / L)患者的血清丙氨酸氨基转移酶(ALT)水平升高( p 0.025)。在大多数肺炎支原体CAP患者中,大环内酯类药物治疗期间ALT升高水平降低,尽管这种降低并不明显。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号